Summary
High-strength CBD CBG CBN Resin, Black Butter
- Made from the pollen of 100% natural Indoor flowers
- Origin: France
- Flavours: Floral, Earthy, Pine
- CBD 51%, CBG 11%, CBN 9%
- Oily, soft texture
See all products:
Details
High-strength CBD CBG CBN Resin, Black Butter
This Black Butter CBD resin is made in France. Inspired by an Afghan hash, it is produced in Savoie from flowers grown in France. It has a beautiful brown colour and a very malleable, rich, oily, soft texture that is very rich in terpenes.
Its natural aromas are also reminiscent of the premium hemp flowers it comes from.
It contains 51% CBD, as well as 11% CBG (cannabigerol) and 9% CBN (cannabinol).
Production method
Grown in France without pesticides or GMOs. Only natural products were used in the production process.
Concentration
- CBD: 51.25%
- CBG: 11.38%
- CBN: 8.97%
- THC: 0.18%
Certification
Product grown in France, then certified by an independent, GMP-approved European laboratory. The certificate of analysis for this product can be found among the photos displayed on this page.
Legislation
100% legal product throughout the European Union. This resin also comes from varieties authorised in the European catalogue.
*Non-contractual photos, taken by us from the harvests currently on sale*
Flavours
High-strength CBD CBG CBN Hash, Black Butter
- Floral
- Earthy
- Pine
Similar products
Discover our other CBD resins with CBG and CBN:
Sources and references (4)
Official and scientific sources on the regulation, safety, composition and quality of this type of product. They are provided for information and are not health claims.
- (2016). Phytocannabinoids: a unified critical inventory. Natural Product Reports. View the source
- (2025). Minor Cannabinoid Profile of Unregulated Cannabidiol Products. Cannabis and Cannabinoid Research. View the source
- (1990). Stability of cannabinoids in dried samples of cannabis dating from around 1896-1905. Journal of Ethnopharmacology. View the source
- (2023). Cannabidiol : analyse de produits « CBD non pharmaceutiques » disponibles sur le marché en France. MILDECA — drogues.gouv.fr (rapport CEIP-A financé par la MILDECA). View the source